A 53-YEAR-OLD MAN had a 1-month history of headaches, lethargy, decreased libido, and increased thirst. Subsequently, he developed diplopia, bitemporal hemianopsia, and a right third nerve palsy. He recently had 1 bout of hematuria following exercise. His physical examination was otherwise unrevealing. His medical, surgical, and family history were unremarkable. Endocrine testing revealed panhypopituitarism and diabetes insipidus (DI); urinalysis showed microscopic hematuria. Magnetic resonance imaging demonstrated an enhancing, invasive sellar and parasellar mass (Figure 1, A-C). Transsphenoidal decompression and subtotal resection were performed, with resolution of his headache and improvement in his visual field deficits and diplopia. Diabetes insipidus and hypopituitarism persisted. A clear cell carcinoma was identified histologically (Figure 1, D-E). Results of a workup revealed a 6-cm solid mass in the right kidney, which was resected. The patient received fractionated radiotherapy to the parasellar region, with stabilization of his residual metastatic pituitary disease. He died of disseminated systemic disease at 12 months.
Magnetic resonance imaging (MRI) and microscopic views of the tumor. A, Coronal, nonenhanced, T1-weighted image. B and C, Coronal (B) and axial (C), T1-weighted, gadolinium-enhanced MRIs of the tumor. There is homogeneous enhancement of the tumor, which fills the sella and suprasellar spaces, compresses the optic apparatus, and invades the cavernous sinuses, especially on the right. D and E, Low-power (D) and high-power (E) views of a clear cell carcinoma, consistent with renal cell metastasis. Microscopically, this tumor consists of large cells with a clear cytoplasm surrounded by a sharply demarcated cell membrane. Nuclei are located centrally, with mild atypia. There are solid nests of tumor cells surrounded by a scant, sinusoidal stroma (arrows, D) and narrow endothelial channels containing erythrocytes (arrow, E).
Thank you for submitting a comment on this article. It will be reviewed by JAMA Neurology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.